Description
Unlocking the science of wakefulness and why modern treatments are targeting specific receptors. This guide uses the metaphor of “keys” and “locks” to explain that while Type 1 Narcolepsy patients lose their “key makers” (orexin-producing neurons), the “locks” (receptors) in the brain remain functional. It clarifies that new orexin agonists are like selective master keys designed to mimic Orexin B to restore the sleep/wake switch. However, it also highlights that since these treatments focus primarily on wakefulness, other symptoms like brain fog and fragmented sleep – managed by the “conductor” Orexin A – may still need attention.
